Rheumatology
Guidelines
EULAR issues imaging recommendations for crystal-induced arthropathies
The document provides guidance on using imaging in both the diagnosis and management of all common forms of crystal-induced arthropathies.
From the Journals
Methotrexate does not impair sperm quality, small study finds
The findings provide reassurance that men can start methotrexate therapy while actively pursuing parenthood.
Feature
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
SmithRx, which bills itself as “next-generation pharmacy benefits management,” announced that it will offer Yusimry to its members at a discount...
Conference Coverage
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
EULAR 2023 served up a bevy of studies on the protection and safety of COVID vaccines for patients and pregnant and breastfeeding women, as well...
Guidelines
New EULAR lupus recommendations advise using biologics, tapering steroids
The 2023 recommendations cover new treatment strategies with more ambitious goals, new data on adverse effects of chronic glucocorticoid use, and...
Conference Coverage
Patient selection key to lowering placebo response rates in lupus clinical trials
High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.
Conference Coverage
Strategies for complete B-cell depletion evolve for patients with lupus nephritis
Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment...
Conference Coverage
High-intensity interval training has sustainable effects in patients with inflammatory arthritis
Patients in a randomized trial improved their cardiorespiratory fitness, but the positive response did not coincide with changes in pain or...
Conference Coverage
Dazodalibep may mitigate Sjögren’s syndrome, but more data are needed
The novel agent targets CD40 ligand and showed promising results in a two-stage, phase 2 clinical trial, particularly for patients with notable...
Feature
Why not both? Dual biologics for treatment-resistant RA and PsA
Previous clinical trials of dual biologic therapies have raised safety issues, but more recent, promising findings from clinical trials and case...
Guidelines
EULAR PsA recommendations update emphasizes safety, nonmusculoskeletal manifestations
The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across...